HempNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) Enters Doctor Practitioner Space with Large-Scale Distribution Agreement

January 21, 2021 10:21:31

HempFusion Wellness Inc. (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has entered into a large-scale distribution agreement with Fullscript.com to launch a doctor practitioner sales channel. Fullscript is a leading eCommerce platform designed to allow health professionals to dispense professional-grade natural health products. Based on the agreement, HempFusion’s seven Biome Research SKUs will be available from Fullscript distribution centers, effective Feb. 2, 2021. The agreement is a significant step in HempFusion’s strategy to enter into the doctor practitioner sales space. Fullscript has become one of the largest distributors in the doctor practitioner sector; the platform offers nutritional supplements to more than 80,000 practitioners and more than 600,000 patients in both the United States and Canada. “We are incredibly excited to launch doctor practitioner sales starting with Biome Research, a specialized wholly owned HempFusion brand designed specifically for doctors, practitioners and their patients,” said HempFusion director of doctor/practitioner Nancy Angelini in the press release. “An industry-leading eCommerce platform like Fullscript, with a deep and established distribution network, is a tremendous advantage to HempFusion. We expect this channel to drive significant revenue growth for the company.”

To view the full press release, visit https://cnw.fm/glQfw

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.